{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P25713","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.orpha.net/ORDO/Orphanet_3389","name":"tuberculosis"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/330","resource_score":{"type":"summed_total","value":14.2,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/330","mined_sentences":[{"section":"title","t_start":70,"t_end":93,"d_start":206,"d_end":217,"text":"Conditions for production, and some characteristics, of mycobacterial growth inhibitory factor produced by spleen cells from mice immunized with viable cells of the attenuated H37Ra strain of Mycobacterium tuberculosis."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1975-10-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P25713","publicationIDs":"http://europepmc.org/abstract/MED/330","disease_uri":"http://www.orpha.net/ORDO/Orphanet_3389"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/330"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P17735","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0000616","name":"tumor"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/337","resource_score":{"type":"summed_total","value":17.2,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/337","mined_sentences":[{"section":"title","t_start":0,"t_end":24,"d_start":50,"d_end":54,"text":"Tyrosine aminotransferase induction in normal and tumor-bearing chickens."},{"section":"abstract","t_start":0,"t_end":24,"d_start":88,"d_end":92,"text":"Tyrosine aminotransferase (TAT) induction by glucagon and dexamethasone in the liver of tumor-bearing chickens was studied and compared with induction in healthy animals."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1975-12-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P17735","publicationIDs":"http://europepmc.org/abstract/MED/337","disease_uri":"http://www.ebi.ac.uk/efo/EFO_0000616"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/337"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P25021","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0007549","name":"Zollinger-Ellison syndrome"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/616","resource_score":{"type":"summed_total","value":14.0,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/616","mined_sentences":[{"section":"title","t_start":15,"t_end":35,"d_start":87,"d_end":112,"text":"The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1976-01-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P25021","publicationIDs":"http://europepmc.org/abstract/MED/616","disease_uri":"http://www.ebi.ac.uk/efo/EFO_0007549"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/616"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P25021","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://purl.obolibrary.org/obo/HP_0002014","name":"diarrhea"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/653","resource_score":{"type":"summed_total","value":7.2,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/653","mined_sentences":[{"section":"abstract","t_start":13,"t_end":34,"d_start":140,"d_end":147,"text":"Metiamide an histamine H2-receptors antagonist has been used to treat a case of Zollinger-Ellison syndrome characterized by a long standing diarrhea, an important gastric hypersecretion and a moderatly elevated plasma gastrin but without digestive ulceration."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1975-10-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P25021","publicationIDs":"http://europepmc.org/abstract/MED/653","disease_uri":"http://purl.obolibrary.org/obo/HP_0002014"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/653"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P25021","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0007549","name":"Zollinger-Ellison syndrome"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/653","resource_score":{"type":"summed_total","value":7.2,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/653","mined_sentences":[{"section":"abstract","t_start":13,"t_end":34,"d_start":80,"d_end":105,"text":"Metiamide an histamine H2-receptors antagonist has been used to treat a case of Zollinger-Ellison syndrome characterized by a long standing diarrhea, an important gastric hypersecretion and a moderatly elevated plasma gastrin but without digestive ulceration."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1975-10-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P25021","publicationIDs":"http://europepmc.org/abstract/MED/653","disease_uri":"http://www.ebi.ac.uk/efo/EFO_0007549"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/653"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P15289","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0000729","name":"ulcerative colitis"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/747","resource_score":{"type":"summed_total","value":8.2,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/747","mined_sentences":[{"section":"abstract","t_start":120,"t_end":122,"d_start":264,"d_end":281,"text":"A simple and convenient colorimetric method is described for the quantitative determination of 5-aminosalicylic acid (5-ASA) and N-acetyl-5-ASA in urine and feces after oral administration of salicylazosulfa-pyridine (SASP), the drug of choice in the treatment of ulcerative colitis."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1975-11-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P15289","publicationIDs":"http://europepmc.org/abstract/MED/747","disease_uri":"http://www.ebi.ac.uk/efo/EFO_0000729"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/747"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P15289","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.orpha.net/ORDO/Orphanet_512","name":"Metachromatic leukodystrophy"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/828","resource_score":{"type":"summed_total","value":14.0,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/828","mined_sentences":[{"section":"title","t_start":72,"t_end":92,"d_start":12,"d_end":39,"text":"Discussion: Metachromatic leukodystrophy, an unusual case with a subtle cerebroside sulfatase defect."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1975-01-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P15289","publicationIDs":"http://europepmc.org/abstract/MED/828","disease_uri":"http://www.orpha.net/ORDO/Orphanet_512"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/828"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P22303","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0002686","name":"atopy"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/857","resource_score":{"type":"summed_total","value":14.0,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/857","mined_sentences":[{"section":"title","t_start":0,"t_end":19,"d_start":75,"d_end":79,"text":"Acetylcholinesterase in atopic skin in relation to the B blockade model of atopy."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1975-06-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P22303","publicationIDs":"http://europepmc.org/abstract/MED/857","disease_uri":"http://www.ebi.ac.uk/efo/EFO_0002686"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/857"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P15289","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.orpha.net/ORDO/Orphanet_512","name":"MLD"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/985","resource_score":{"type":"summed_total","value":7.4,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/985","mined_sentences":[{"section":"abstract","t_start":163,"t_end":177,"d_start":142,"d_end":144,"text":"Results from our study suggest an intricate nature of this dysmetabolic disorder, which shows ultrastructural changes usually seen in classic MLD, a deficiency of arylsulfatase A only, concomitant with those seen in mucopolysaccharidoses such as Hurler and Sanfilippo syndromes."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1975-12-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P15289","publicationIDs":"http://europepmc.org/abstract/MED/985","disease_uri":"http://www.orpha.net/ORDO/Orphanet_512"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/985"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P17752","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0000616","name":"tumors"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/1140","resource_score":{"type":"summed_total","value":7.4,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/1140","mined_sentences":[{"section":"abstract","t_start":185,"t_end":187,"d_start":210,"d_end":215,"text":"Biochemical differences in tumor groups probably reflected variations in the proportion of neuroepithelial components: trends suggested an increase of cAMP and an increased activity of TPH, AADC, TH and DBH in tumors with increased proportions of neuroepithelial cells."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1976-01-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P17752","publicationIDs":"http://europepmc.org/abstract/MED/1140","disease_uri":"http://www.ebi.ac.uk/efo/EFO_0000616"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/1140"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P09172","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0000616","name":"tumors"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/1140","resource_score":{"type":"summed_total","value":7.6,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/1140","mined_sentences":[{"section":"abstract","t_start":203,"t_end":205,"d_start":210,"d_end":215,"text":"Biochemical differences in tumor groups probably reflected variations in the proportion of neuroepithelial components: trends suggested an increase of cAMP and an increased activity of TPH, AADC, TH and DBH in tumors with increased proportions of neuroepithelial cells."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1976-01-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P09172","publicationIDs":"http://europepmc.org/abstract/MED/1140","disease_uri":"http://www.ebi.ac.uk/efo/EFO_0000616"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/1140"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P20711","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0000616","name":"tumors"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/1140","resource_score":{"type":"summed_total","value":7.4,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/1140","mined_sentences":[{"section":"abstract","t_start":190,"t_end":193,"d_start":210,"d_end":215,"text":"Biochemical differences in tumor groups probably reflected variations in the proportion of neuroepithelial components: trends suggested an increase of cAMP and an increased activity of TPH, AADC, TH and DBH in tumors with increased proportions of neuroepithelial cells."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1976-01-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P20711","publicationIDs":"http://europepmc.org/abstract/MED/1140","disease_uri":"http://www.ebi.ac.uk/efo/EFO_0000616"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/1140"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P04278","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0004562","name":"cryptorchidism"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/1296","resource_score":{"type":"summed_total","value":8.2,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/1296","mined_sentences":[{"section":"abstract","t_start":55,"t_end":57,"d_start":155,"d_end":168,"text":"The production of testicular androgen-binding protein (ABP), as a measure of Sertoli cell function, was studied after unilateral or bilateral experimental cryptorchidism in adult rats."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1975-12-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P04278","publicationIDs":"http://europepmc.org/abstract/MED/1296","disease_uri":"http://www.ebi.ac.uk/efo/EFO_0004562"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/1296"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P28300","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.orpha.net/ORDO/Orphanet_209","name":"cutis laxa"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/1448","resource_score":{"type":"summed_total","value":7.2,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/1448","mined_sentences":[{"section":"abstract","t_start":287,"t_end":299,"d_start":323,"d_end":332,"text":"Thus far, the primary heritable disorders of collagen metabolism in man include lysyl hydroxylase deficiency in Ehlers-Danlos syndrome type VI, p-collagen peptidase deficency in Ehlers-Danlos syndrome type VII, decreased synthesis of type III collagen in Ehlers-Danlos syndrome type IV, lysyl oxidase deficency in S-linked cutis laxa and Ehlers-Danlos syndrome type V, and decreased synthesis of type I collagen in osteogenesis imperfecta."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1976-02-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P28300","publicationIDs":"http://europepmc.org/abstract/MED/1448","disease_uri":"http://www.orpha.net/ORDO/Orphanet_209"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/1448"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P28300","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.orpha.net/ORDO/Orphanet_286","name":"Ehlers-Danlos syndrome type IV"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/1448","resource_score":{"type":"summed_total","value":7.2,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/1448","mined_sentences":[{"section":"abstract","t_start":287,"t_end":299,"d_start":255,"d_end":284,"text":"Thus far, the primary heritable disorders of collagen metabolism in man include lysyl hydroxylase deficiency in Ehlers-Danlos syndrome type VI, p-collagen peptidase deficency in Ehlers-Danlos syndrome type VII, decreased synthesis of type III collagen in Ehlers-Danlos syndrome type IV, lysyl oxidase deficency in S-linked cutis laxa and Ehlers-Danlos syndrome type V, and decreased synthesis of type I collagen in osteogenesis imperfecta."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1976-02-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P28300","publicationIDs":"http://europepmc.org/abstract/MED/1448","disease_uri":"http://www.orpha.net/ORDO/Orphanet_286"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/1448"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P28300","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.orpha.net/ORDO/Orphanet_666","name":"osteogenesis imperfecta"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/1448","resource_score":{"type":"summed_total","value":7.2,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/1448","mined_sentences":[{"section":"abstract","t_start":287,"t_end":299,"d_start":415,"d_end":437,"text":"Thus far, the primary heritable disorders of collagen metabolism in man include lysyl hydroxylase deficiency in Ehlers-Danlos syndrome type VI, p-collagen peptidase deficency in Ehlers-Danlos syndrome type VII, decreased synthesis of type III collagen in Ehlers-Danlos syndrome type IV, lysyl oxidase deficency in S-linked cutis laxa and Ehlers-Danlos syndrome type V, and decreased synthesis of type I collagen in osteogenesis imperfecta."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1976-02-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P28300","publicationIDs":"http://europepmc.org/abstract/MED/1448","disease_uri":"http://www.orpha.net/ORDO/Orphanet_666"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/1448"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P28300","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.orpha.net/ORDO/Orphanet_98249","name":"Ehlers-Danlos syndrome"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/1448","resource_score":{"type":"summed_total","value":7.2,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/1448","mined_sentences":[{"section":"abstract","t_start":287,"t_end":299,"d_start":112,"d_end":133,"text":"Thus far, the primary heritable disorders of collagen metabolism in man include lysyl hydroxylase deficiency in Ehlers-Danlos syndrome type VI, p-collagen peptidase deficency in Ehlers-Danlos syndrome type VII, decreased synthesis of type III collagen in Ehlers-Danlos syndrome type IV, lysyl oxidase deficency in S-linked cutis laxa and Ehlers-Danlos syndrome type V, and decreased synthesis of type I collagen in osteogenesis imperfecta."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1976-02-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P28300","publicationIDs":"http://europepmc.org/abstract/MED/1448","disease_uri":"http://www.orpha.net/ORDO/Orphanet_98249"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/1448"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/P05155","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.orpha.net/ORDO/Orphanet_91378","name":"hereditary angioneurotic edema"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/1449","resource_score":{"type":"summed_total","value":7.2,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/1449","mined_sentences":[{"section":"abstract","t_start":75,"t_end":95,"d_start":23,"d_end":52,"text":"Serum of patients with hereditary angioneurotic edema having no functional C1-esterase inhibitor was as effective in inhibiting the proteolysis as normal serum."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1976-02-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/P05155","publicationIDs":"http://europepmc.org/abstract/MED/1449","disease_uri":"http://www.orpha.net/ORDO/Orphanet_91378"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/1449"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/Q03701","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0000556","name":"ischemia"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/1473","resource_score":{"type":"summed_total","value":7.6,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/1473","mined_sentences":[{"section":"abstract","t_start":41,"t_end":43,"d_start":101,"d_end":108,"text":"No correlation was found between average CBF and clinical condition, and neither global nor regional ischemia contributed significantly to the reduced brain function."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1976-02-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/Q03701","publicationIDs":"http://europepmc.org/abstract/MED/1473","disease_uri":"http://www.ebi.ac.uk/efo/EFO_0000556"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/1473"}]}}
{"type":"literature","sourceID":"europepmc","target":{"activity":"http://identifiers.org/cttv.activity/up_or_down","id":"http://identifiers.org/uniprot/O00767","target_type":"http://identifiers.org/cttv.target/protein_evidence"},"disease":{"id":"http://www.ebi.ac.uk/efo/EFO_0000616","name":"tumor"},"evidence":{"unique_experiment_reference":"http://europepmc.org/abstract/MED/1624","resource_score":{"type":"summed_total","value":7.4,"method":{"description":"Custom text-mining method for target-disease association"}},"literature_ref":{"lit_id":"http://europepmc.org/abstract/MED/1624","mined_sentences":[{"section":"abstract","t_start":180,"t_end":202,"d_start":81,"d_end":85,"text":"These observations suggest that (a) a major portion of the oleate in the mammary tumor is not produced within the tissue, (b) dietary adaptation is not a general characteristic of stearoyl-CoA desaturase in neoplastic tissues, and (c) enhanced desaturase activity in liver is directly related to the absence of linoleate or oleate, or to a large decrease in oleate in the diet."}]},"provenance_type":{"database":{"version":"2019-05-24","id":"EuropePMC"}},"is_associated":true,"date_asserted":"1975-12-01T00:00:00Z","evidence_codes":["http://www.targetvalidation.org/evidence/literature_mining","http://purl.obolibrary.org/obo/ECO_0000213"]},"validated_against_schema_version":"1.5.0","access_level":"public","unique_association_fields":{"target":"http://identifiers.org/uniprot/O00767","publicationIDs":"http://europepmc.org/abstract/MED/1624","disease_uri":"http://www.ebi.ac.uk/efo/EFO_0000616"},"literature":{"references":[{"lit_id":"http://europepmc.org/abstract/MED/1624"}]}}
